HOME >> MEDICINE >> NEWS
Profiles of myocardial infarction among South Asian Canadians

South Asian Canadians (those from India, Pakistan, Sri Lanka and Bangladesh) have higher rates of myocardial infarction (MI) than Canadians of European origin.

Exploring these differences, Dr. Sonia Anand and colleagues studied 553 South Asians and 553 non-South Asians matched by age, sex, discharge date and hospital of admission. The groups were compared in terms of presentation characteristics, cardiac risk factors and in-hospital outcomes.

The authors found that, on average, South Asian patients took longer to present to hospital (3.92 v. 3.08 hours, p= 0.04) and were more likely to have diabetes (43.4% v. 28.2%, p < 0.001) despite having a lower body mass index (25.7 v. 28.0 p = 0.05). However, the authors also found they were less likely to be smokers (29.3% v. 67.8%, p < 0.001) or to have pre-existing cardiovascular disease (49.4% v. 55.0%, p = 0.04). Despite their differences, the 2 groups had similar MI mortality and in-hospital outcomes. The authors recommend public health efforts focused on increasing the awareness of the symptoms of acute MI in South Asian communities as a means to raise awareness.

p. 717 Risk factors, hospital management and outcomes after acute myocardial infarction in South Asian Canadians and matched control subjects
S. Anand et al


'"/>

Contact: Dr. Sonia Anand
905-525-9140 x22169
Canadian Medical Association Journal
18-Mar-2002


Page: 1

Related medicine news :

1. Size of myocardial infarct measured using MRI
2. No link between oral contraceptives and myocardial infarction
3. Mouse gene shows new mechanism behind cardiac infarction in man
4. Novel use of radiotracer reveals extent of mycoardial infarction damage
5. Sexual lifestyles vary among ethnic groups in Britain
6. Bullying among sixth graders a daily occurrence, UCLA study finds
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Sudan surveys show high rates of death and malnutrition among displaced population
9. UW research shows risk factors for relapse among health care professionals who abuse drugs
10. Stroke awareness low among women, especially minorities
11. Use of potentially inappropriate medications among elderly common in some European countries

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Profiles myocardial infarction among South Asian Canadians

(Date:5/18/2013)... few extra cups of coffee each month might help ... as primary sclerosing cholangitis (PSC), a new study suggests. ... found that drinking coffee was associated with a reduced ... cirrhosis of the liver, liver failure and biliary cancer. ... "While rare, PSC has extremely detrimental effects," ...
(Date:5/18/2013)... 18, 2013) There are significant cost and ... to diagnose or treat gastrointestinal problems, according to ... , A study by New York Presbyterian Hospital ... testing may substantially reduce the cost and risk ... is believed to affect nearly 25 percent of ...
(Date:5/18/2013)... 2013 Assisted living and retirement ... safety and comfort of their residents. Systems Technologies ... with an effective and cost-efficient solution – VisionLink ... integrated, turnkey communications solution that helps nurses provide ... independence and privacy. , The VisionLink ...
(Date:5/18/2013)... 2013 Transvaginal mesh lawsuits ... move forward in a consolidated litigation underway in New ... According to a notice on the Court’s website, the ... litigation will be held on Wednesday, May 22nd. ... in the proceeding on behalf of women who suffered ...
(Date:5/18/2013)... The “World Healthcare IT Market: Trends & Forecast (2010 ... restraints, and opportunities in North America, Europe, Asia, & ... 89 market data tables , ... , http://www.marketsandmarkets.com/Market-Reports/healthcare-information-technology-market-136.html , Early buyers ... healthcare IT market is expected to grow from $99.6 ...
Breaking Medicine News(10 mins):Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2Health News:New research identifies practice changes to improve value and quality of GI procedures 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 2Health News:VisionLink Nurse Call System's New Features Serve the Unique Needs of Retirement Communities 3Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 3Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3
(Date:5/17/2013)... BEIJING , May 17, 2013 Sinovac Biotech ... vaccines in China , today announced that ... quarter ended March 31, 2013, before market on Tuesday, May ... Tuesday, May 28, 2013, at 8:00 a.m. EDT (May 28, ... Company,s financial results and provide an update on recent corporate ...
(Date:5/16/2013)... ZURICH , May 17, 2013 ... and Research (A*STAR) and Switzerland,s Cytos ... been dosed in a Phase 1 clinical trial with their ... virus-like particle (VLP) technology. In this first Phase 1 clinical ... and its potential to protect against H1N1 influenza infection will ...
(Date:5/16/2013)... 16, 2013  PTC Therapeutics, Inc., today announced that ... with the U.S. Securities and Exchange Commission ("SEC") relating ... stock. The number of shares to be offered and ... determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) ... joint book-running managers for the offering. Cowen and Company ...
Breaking Medicine Technology:Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 2Sinovac to Host Conference Call to Report First Quarter 2013 Unaudited Financial Results 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 2A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 3A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 4A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 5A*STAR and Cytos Bring Singapore's First Influenza Vaccine to Clinical Testing 6PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
Cached News: